As an immunomodulatory targeted drug, Pomalidomide offer a crucial therapeutic option for adult patients with relapsed and refractory multiple myeloma who progressed after at least two prior treatments including lenalidomide and a proteasome inhibitor.
Authentic
Guarantee
Fast Delivery
Privacy Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



